Results
|
6041.
|
PD-L1 (B7-H1) Competes with the RNA Exosome to Regulate the DNA Damage Response and Can Be Targeted to Sensitize to Radiation or Chemotherapy. [electronic resource] by
- Tu, Xinyi
- Qin, Bo
- Zhang, Yong
- Zhang, Cheng
- Kahila, Mohamed
- Nowsheen, Somaira
- Yin, Ping
- Yuan, Jian
- Pei, Huadong
- Li, Hu
- Yu, Jia
- Song, Zhiwang
- Zhou, Qin
- Zhao, Fei
- Liu, Jiaqi
- Zhang, Chao
- Dong, Haidong
- Mutter, Robert W
- Lou, Zhenkun
Producer: 20200113
In:
Molecular cell vol. 74
Availability: No items available.
|
|
6042.
|
Shieldin complex promotes DNA end-joining and counters homologous recombination in BRCA1-null cells. [electronic resource] by
- Dev, Harveer
- Chiang, Ting-Wei Will
- Lescale, Chloe
- de Krijger, Inge
- Martin, Alistair G
- Pilger, Domenic
- Coates, Julia
- Sczaniecka-Clift, Matylda
- Wei, Wenming
- Ostermaier, Matthias
- Herzog, Mareike
- Lam, Jonathan
- Shea, Abigail
- Demir, Mukerrem
- Wu, Qian
- Yang, Fengtang
- Fu, Beiyuan
- Lai, Zhongwu
- Balmus, Gabriel
- Belotserkovskaya, Rimma
- Serra, Violeta
- O'Connor, Mark J
- Bruna, Alejandra
- Beli, Petra
- Pellegrini, Luca
- Caldas, Carlos
- Deriano, Ludovic
- Jacobs, Jacqueline J L
- Galanty, Yaron
- Jackson, Stephen P
Producer: 20190415
In:
Nature cell biology vol. 20
Availability: No items available.
|
|
6043.
|
ALDH1A1 Contributes to PARP Inhibitor Resistance via Enhancing DNA Repair in BRCA2 [electronic resource] by
- Liu, Lu
- Cai, Shurui
- Han, Chunhua
- Banerjee, Ananya
- Wu, Dayong
- Cui, Tiantian
- Xie, Guozhen
- Zhang, Junran
- Zhang, Xiaoli
- McLaughlin, Eric
- Yin, Ming
- Backes, Floor J
- Chakravarti, Arnab
- Zheng, Yanfang
- Wang, Qi-En
Producer: 20201209
In:
Molecular cancer therapeutics vol. 19
Availability: No items available.
|
|
6044.
|
|
|
6045.
|
BRCA1/2 test results impact risk management attitudes, intentions, and uptake. [electronic resource] by
- O'Neill, Suzanne C
- Valdimarsdottir, Heiddis B
- Demarco, Tiffani A
- Peshkin, Beth N
- Graves, Kristi D
- Brown, Karen
- Hurley, Karen E
- Isaacs, Claudine
- Hecker, Sharon
- Schwartz, Marc D
Producer: 20110218
In:
Breast cancer research and treatment vol. 124
Availability: No items available.
|
|
6046.
|
A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancer. [electronic resource] by
- Ratner, E S
- Keane, F K
- Lindner, R
- Tassi, R A
- Paranjape, T
- Glasgow, M
- Nallur, S
- Deng, Y
- Lu, L
- Steele, L
- Sand, S
- Muller, R-U
- Bignotti, E
- Bellone, S
- Boeke, M
- Yao, X
- Pecorelli, S
- Ravaggi, A
- Katsaros, D
- Zelterman, D
- Cristea, M C
- Yu, H
- Rutherford, T J
- Weitzel, J N
- Neuhausen, S L
- Schwartz, P E
- Slack, F J
- Santin, A D
- Weidhaas, J B
Producer: 20130124
In:
Oncogene vol. 31
Availability: No items available.
|
|
6047.
|
Drug repurposing screen identifies lestaurtinib amplifies the ability of the poly (ADP-ribose) polymerase 1 inhibitor AG14361 to kill breast cancer associated gene-1 mutant and wild type breast cancer cells. [electronic resource] by
- Vazquez-Ortiz, Guelaguetza
- Chisholm, Cristine
- Xu, Xiaoling
- Lahusen, Tyler J
- Li, Cuiling
- Sakamuru, Srilatha
- Huang, Ruili
- Thomas, Craig J
- Xia, Menghang
- Deng, Chuxia
Producer: 20150416
In:
Breast cancer research : BCR vol. 16
Availability: No items available.
|
|
6048.
|
The Hsp90 inhibitor SNX-7081 is synergistic with fludarabine nucleoside via DNA damage and repair mechanisms in human, p53-negative chronic lymphocytic leukemia. [electronic resource] by
- Kaufman, Kimberley L
- Jenkins, Yiping
- Alomari, Munther
- Mirzaei, Mehdi
- Best, O Giles
- Pascovici, Dana
- Mactier, Swetlana
- Mulligan, Stephen P
- Haynes, Paul A
- Christopherson, Richard I
Producer: 20160928
In:
Oncotarget vol. 6
Availability: No items available.
|
|
6049.
|
Molecular profiling of human mammary gland links breast cancer risk to a p27(+) cell population with progenitor characteristics. [electronic resource] by
- Choudhury, Sibgat
- Almendro, Vanessa
- Merino, Vanessa F
- Wu, Zhenhua
- Maruyama, Reo
- Su, Ying
- Martins, Filipe C
- Fackler, Mary Jo
- Bessarabova, Marina
- Kowalczyk, Adam
- Conway, Thomas
- Beresford-Smith, Bryan
- Macintyre, Geoff
- Cheng, Yu-Kang
- Lopez-Bujanda, Zoila
- Kaspi, Antony
- Hu, Rong
- Robens, Judith
- Nikolskaya, Tatiana
- Haakensen, Vilde D
- Schnitt, Stuart J
- Argani, Pedram
- Ethington, Gabrielle
- Panos, Laura
- Grant, Michael
- Clark, Jason
- Herlihy, William
- Lin, S Joyce
- Chew, Grace
- Thompson, Erik W
- Greene-Colozzi, April
- Richardson, Andrea L
- Rosson, Gedge D
- Pike, Malcolm
- Garber, Judy E
- Nikolsky, Yuri
- Blum, Joanne L
- Au, Alfred
- Hwang, E Shelley
- Tamimi, Rulla M
- Michor, Franziska
- Haviv, Izhak
- Liu, X Shirley
- Sukumar, Saraswati
- Polyak, Kornelia
Producer: 20140130
In:
Cell stem cell vol. 13
Availability: No items available.
|
|
6050.
|
Synthetic Lethality of PARP Inhibitors in Combination with MYC Blockade Is Independent of BRCA Status in Triple-Negative Breast Cancer. [electronic resource] by
- Carey, Jason P W
- Karakas, Cansu
- Bui, Tuyen
- Chen, Xian
- Vijayaraghavan, Smruthi
- Zhao, Yang
- Wang, Jing
- Mikule, Keith
- Litton, Jennifer K
- Hunt, Kelly K
- Keyomarsi, Khandan
Producer: 20190116
In:
Cancer research vol. 78
Availability: No items available.
|
|
6051.
|
Rucaparib in relapsed, platinum-sensitive high-grade ovarian carcinoma (ARIEL2 Part 1): an international, multicentre, open-label, phase 2 trial. [electronic resource] by
- Swisher, Elizabeth M
- Lin, Kevin K
- Oza, Amit M
- Scott, Clare L
- Giordano, Heidi
- Sun, James
- Konecny, Gottfried E
- Coleman, Robert L
- Tinker, Anna V
- O'Malley, David M
- Kristeleit, Rebecca S
- Ma, Ling
- Bell-McGuinn, Katherine M
- Brenton, James D
- Cragun, Janiel M
- Oaknin, Ana
- Ray-Coquard, Isabelle
- Harrell, Maria I
- Mann, Elaina
- Kaufmann, Scott H
- Floquet, Anne
- Leary, Alexandra
- Harding, Thomas C
- Goble, Sandra
- Maloney, Lara
- Isaacson, Jeff
- Allen, Andrew R
- Rolfe, Lindsey
- Yelensky, Roman
- Raponi, Mitch
- McNeish, Iain A
Producer: 20170613
In:
The Lancet. Oncology vol. 18
Availability: No items available.
|
|
6052.
|
|
|
6053.
|
|
|
6054.
|
|
|
6055.
|
|
|
6056.
|
|
|
6057.
|
|
|
6058.
|
|
|
6059.
|
KPNA2 is a nuclear export protein that contributes to aberrant localisation of key proteins and poor prognosis of breast cancer. [electronic resource] by
- Alshareeda, A T
- Negm, O H
- Green, A R
- Nolan, C C
- Tighe, P
- Albarakati, N
- Sultana, R
- Madhusudan, S
- Ellis, I O
- Rakha, E A
Producer: 20150909
In:
British journal of cancer vol. 112
Availability: No items available.
|
|
6060.
|
|